United Therapeutics Corp (UTHR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1040 SPRING ST SILVER SPRING, MD 20910

United Therapeutics Corp. develops therapeutics to treat chronic and life-threatening diseases. The company is active in three therapeutic areas: cardiovascular medicine, infectious disease and oncology. Its lead product is Remodulin, for the treatment of pulmonary arterial hypertension in certain patients.

Data based on most recent fiscal year report
Market Cap5.002 Billion Shares Outstanding43.21 Million Avg Volume828.78 Thousand
1-Yr BETA vs S&P TR0.929 Current Ratio3.26 Quick Ratio3.01
View SEC Filings from UTHR instead.
Q2 2019 All Institutions Hedge Funds 1
To trade UTHR now:
Filers who had this stock in their top 10: 3 3 (0.31%)
13F Filers holding this stock: 309 52 (5.37%)
Aggregate 13F shares on 06/30/2019: 41.28 Million 13.168 Million
Aggregate 13F shares on 03/31/2019: 42.224 Million 9.445 Million
Percent change: -2.24% 39.42%
Funds creating new positions: 55 24
Funds Adding to an existing position: 92 16
Funds closing out their position: 104 11
Funds reducing their position: 128 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding UTHR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ZACCARDELLI DAVID PRESIDENT & CEO

76,647 2019-10-01 0

THOMPSON TOMMY G

  • Director
382,706 2019-09-30 4

OLIAN JUDY D.

  • Director
22,313 2019-07-23 1

JEFFS ROGER

  • Director
103,532 2019-07-03 0

CAUSEY CHRISTOPHER

  • Director
0 2019-06-26 5

PATUSKY CHRISTOPHER

  • Director
0 2019-06-26 3

DWEK RAYMOND

  • Director
0 2019-06-26 1

GILTNER RICHARD

  • Director
3,750 2019-06-26 10

KURZWEIL RAY

  • Director
5,240 2019-06-26 1

SULLIVAN LOUIS W

  • Director
5,120 2019-06-26 6

KLEIN KATHERINE J

  • Director
0 2019-06-26 1

MESA NILDA

  • Director
0 2019-06-26 3

MAHON PAUL A EVP & GENERAL COUNSEL

  • Officer
35,823 2019-03-21 12

ROTHBLATT MARTINE A CHAIRMAN & CEO

  • Officer
  • Director
683,795 2019-03-18 14

EDGEMOND JAMES CFO AND TREASURER

  • Officer
753 2019-03-15 2

BENKOWITZ MICHAEL PRESIDENT AND COO

  • Officer
1,690 2019-03-15 2

LILLY ELI & CO

  • 10% Owner
0 2019-03-11 0

FERRARI JOHN MAXIM

  • FORMER CFO
No longer subject to file 2015-03-14 0

GRAY R PAUL

  • FORMER DIRECTOR
No longer subject to file 2014-03-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments